Clinical Trial

ZILRETTA in Subjects With Shoulder Osteoarthritis

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Primary Objective: To assess the efficacy of ZILRETTA on pain following an intra-articular (IA) injection in subjects with glenohumeral osteoarthritis (OA) relative to normal saline placebo Secondary Objective: * To assess the efficacy of ZILRETTA on pain following an IA injection in subjects with glenohumeral OA relative to triamcinolone acetonide injectable suspension, and normal saline placebo * To assess the safety of ZILRETTA in subjects with glenohumeral OA relative to normal saline placebo
Protocol Amendment History 16 amendments
This ClinicalTrials.gov record has been amended 16 times since 2024-02-13; most recent amendment 2026-05-28.
Status change: Recruiting → Active, Not Recruiting 2026-05-28
Trial Details
NCT Number NCT06269705
Lead Sponsor Pacira Pharmaceuticals, Inc
Conditions Glenohumeral Osteoarthritis
Enrollment 150 participants
Start Date 2024-02-05
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-29